Cargando…
A charitable access program for patients with lysosomal storage disorders in underserved communities worldwide
BACKGROUND: Lysosomal storage disorders (LSDs) are rare genetic disorders, with heterogeneous clinical manifestations and severity. Treatment options, such as enzyme replacement therapy (ERT), substrate replacement therapy, and pharmacological chaperone therapy, are available for several LSDs, inclu...
Autores principales: | Mehta, Atul, Ramaswami, Uma, Muenzer, Joseph, Giugliani, Roberto, Ullrich, Kurt, Collin-Histed, Tanya, Panahloo, Zoya, Wellhoefer, Hartmann, Frader, Joel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788852/ https://www.ncbi.nlm.nih.gov/pubmed/33407729 http://dx.doi.org/10.1186/s13023-020-01645-9 |
Ejemplares similares
-
Impact of the COVID-19 pandemic on the standard of care for patients with lysosomal storage diseases: A survey of healthcare professionals in the Fabry, Gaucher, and Hunter Outcome Survey registries
por: Elstein, Deborah, et al.
Publicado: (2021) -
Evaluating enzyme replacement therapies for Anderson-Fabry disease: commentary on a recent report
por: Giugliani, Roberto, et al.
Publicado: (2018) -
La Charite
Publicado: (1829) -
La Charite
Publicado: (1829) -
La Charite
Publicado: (1829)